SuperworthAptevo Therapeutics shares outstanding APVO
Diluted shares outstanding, averaged over each quarter, from 2015.
- Latest quarter, to Jun 30, 2026
- 1.2M
- On a year earlier
- +2817.4%
- more shares
Aptevo Therapeutics had 1.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2817.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2023 | 37 | +308% |
| FY2022 | 9 | +9% |
| FY2021 | 8 | +27% |
| FY2020 | 7 | +19% |
| FY2019 | 6 | +99% |
| FY2018 | 3 | +4% |
| FY2017 | 3 | +8% |
| FY2016 | 2 | +0% |
| FY2015 | 2 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 1.2M | +2817% | |
| Q1 FY26 | 1.1M | +26083% | |
| Q3 FY25 | 224.9K | +28306% | |
| Q2 FY25 | 41K | +15420% | |
| Q1 FY25 | 4.1K | +7758% | |
| Q3 FY24 | 792 | +3590% | |
| Q2 FY24 | 264 | +2289% | |
| Q1 FY24 | 52 | +330% | |
| Q4 FY23 | 37 | +308% | |
| Q3 FY23 | 21 | +147% | |
| Q2 FY23 | 11 | +29% | |
| Q1 FY23 | 12 | +42% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Aptevo Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.